Promega Notes
Explore research trends based on Promega technologies, read customer stories and make your life in the lab a little easier with technical articles.
Feature Story
Metagenomics, Microbes and the Meaning of Life
Dr. Chris Mason’s microbiome research helps us better understand what it means to be human.
Research Highlights
Enhanced Extrinsic Apoptosis of Therapy-Induced Senescent Cancer Cells
Inducing apoptosis in therapy-induced senescent cancer cells could help prevent relapse.
Customer Spotlight
Interviews and case studies featuring novel ways in which our customers are using Promega products
Dr. Alan Richardson’s lab uses the NanoBiT® Protein:Protein Interaction System to measure the association of two proteins involved in autophagosome formation in live cells.
Technical Articles
Immunogenic Cell Death: Methods to Measure Damage Associated Molecular Patterns (DAMP)
Easily monitor immunogenic cell death with two homogeneous, bioluminescent assays.
Lumit™ Cytokine Assays: Interpolating Data with the GloMax® Discover
The GloMax® Discover enables rapid interpolation of unknown cytokine concentrations.
Homogeneous Assays for Triglyceride Metabolism Research
Measuring triglycerides and their metabolism is important for understanding metabolic disease.
Verifying Cell-Based Assays for Use with 3D Models
The use of 3D models provides increased physiological relevance, but it can also present challenges.
Considerations for PCR-Based Viral Assay Development
PCR-based testing is an important tool for detecting SARS-CoV-2 virus in samples.
Promega Connections: Highlights
Popular posts from our science blog
“Forever” Chemicals: Forever No More
Scientists have discovered mild conditions that can destroy several types of so-called “forever chemicals”.
CCNE1-Amplified Cancers Targeted Through Synthetic Lethality Involving PKMYT1 Kinase
A study in Nature uncovers a selective PKYMT1 inhibitor that can target cancer cells through a synthetic lethal approach.
PROTAC Virus Vaccines: A New Approach to Vaccine Development
Scientists working on vaccines are looking for easier-to-deliver, faster-to-develop vaccines. Here we highlight work on PROTAC virus vaccines.
In the News
Business Wire (June 2022): Renewable Sources Now Supplying Over 20% of Promega Global Electricity Use
Biocompare (May 2022): Designing 3D Cell-Based Assays
NBC15 (May 2022): Madison College students showcase robotic systems
Wisconsin State Journal (April 2022): Promega unveils post-doctoral program for scientists to research gene editing
GEN (March 2022): New Methods Enable Earlier Detection of COVID-19 Outbreaks via Wastewater